Dawei Chen
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 44
- Cancer Immunotherapy and Biomarkers 22
- Lung Cancer Research Studies 11
- Inflammatory Biomarkers in Disease Prognosis 8
- Colorectal Cancer Treatments and Studies 4
-
- Gut microbiota and health 4
- Co-authors
- Zengfu Zhang (7 shared papers)Jinming Yu (5 shared papers)Xu Liu (3 shared papers)Vivek Verma (17 shared papers)James W. Welsh (19 shared papers)Hampartsoum B. Barsoumian (13 shared papers)María Angélica Cortez (12 shared papers)Roshal R. Patel (6 shared papers)
- Journals
- Frontiers in Oncology (6 papers)Journal of Clinical Oncology (5 papers)Frontiers in Immunology (5 papers)International Journal of Radiation Oncology*Biology*Physics (5 papers)Oncotarget (4 papers)
- Partner nations
- ChinaUnited StatesTürkiye
In The Last Decade
Dawei Chen
86 papers receiving 2.6k citations
Dawei Chen's Hit Papers
Peers
Comparison fields: 5 of 94
- Oncology 1.3k
- Immunology 528
- Pulmonary and Respiratory Medicine 650
- Cancer Research 277
- Radiology, Nuclear Medicine and Imaging 191
Countries citing papers authored by Dawei Chen
This map shows the geographic impact of Dawei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Chen more than expected).
Fields of papers citing papers by Dawei Chen
This network shows the impact of papers produced by Dawei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Chen. The network helps show where Dawei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Dawei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Radiotherapy combined with immunotherapy: the dawn of cancer treatment Hit paper breakdown → | 2022 | 426 |
| 2 | Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials Hit paper breakdown → | 2020 | 376 |
| 3 | 2020 | 194 | |
| 4 | 2020 | 107 | |
| 5 | 2020 | 88 | |
| 6 | Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN Hit paper breakdown → | 2024 | 85 |
| 7 | 2013 | 73 | |
| 8 | 2020 | 73 | |
| 9 | 2020 | 71 | |
| 10 | 2021 | 65 | |
| 11 | 2020 | 64 | |
| 12 | 2019 | 62 | |
| 13 | 2021 | 60 | |
| 14 | 2022 | 54 | |
| 15 | 2021 | 44 | |
| 16 | 2019 | 42 | |
| 17 | 2020 | 40 | |
| 18 | 2018 | 39 | |
| 19 | 2022 | 38 | |
| 20 | 2023 | 34 |
About Dawei Chen
Dawei Chen is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 94 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (22 papers), Lung Cancer Research Studies (11 papers), Immunotherapy and Immune Responses (10 papers), Inflammatory Biomarkers in Disease Prognosis (8 papers), Lung Cancer Diagnosis and Treatment (7 papers), Gut microbiota and health (4 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Oncology (1.3k citations), Immunology (528 citations), Pulmonary and Respiratory Medicine (650 citations), Cancer Research (277 citations) and Radiology, Nuclear Medicine and Imaging (191 citations). Dawei Chen has collaborated with scholars based in China, United States and Türkiye. Frequent co-authors include Zengfu Zhang, Jinming Yu, Xu Liu, Vivek Verma, James W. Welsh, Hampartsoum B. Barsoumian, María Angélica Cortez, Roshal R. Patel, Jinming Yu and Joe Y. Chang. Their work appears in journals such as Frontiers in Oncology, Journal of Clinical Oncology, Frontiers in Immunology, International Journal of Radiation Oncology*Biology*Physics and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.